DalsnaFinance › IPOs › Evommune, Inc.
Evommune, Inc. completed its initial public offering on NYSE on November 6, 2025, pricing at $16.00 a share.
| Ticker | EVMN |
|---|---|
| Exchange | NYSE |
| Status | Completed |
| Listing date | November 6, 2025 |
| Offering price | $16.00 |
| Shares offered | 9,375,000 |
| Total raised | $150M |
Evommune, Inc. — quote, profile and latest news →
IPO data is compiled from SEC filings. This page is general information, not investment advice.